EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, MeiraGTx Holdings's enterprise value is $273.51 Mil.
MeiraGTx Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $14.02 Mil. Therefore, MeiraGTx Holdings's EV-to-Revenue for today is 19.51.
The historical rank and industry rank for MeiraGTx Holdings's EV-to-Revenue or its related term are showing as below:
MGTX'
s EV-to-Revenue Range Over the Past 10 Years
Min: 5.6 Med: 24.87 Max: 700.43
Current: 19.51
During the past 8 years, the highest EV-to-Revenue of MeiraGTx Holdings was 700.43. The lowest was 5.60. And the median was 24.87.
MGTX's EV-to-Revenue is ranked worse than 67.7% of 1031
companies
in the Biotechnology industry
Industry Median: 7.91
vs MGTX: 19.51
The historical data trend for MeiraGTx Holdings's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of MeiraGTx Holdings's EV-to-Revenue
For the Biotechnology subindustry, MeiraGTx Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MeiraGTx Holdings's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, MeiraGTx Holdings's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where MeiraGTx Holdings's EV-to-Revenue falls into.
MeiraGTx Holdings's current Enterprise Value is $273.51 Mil.
MeiraGTx Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $14.02 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MeiraGTx Holdings's share price for today is $4.97.
MeiraGTx Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.25.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MeiraGTx Holdings EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of MeiraGTx Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
MeiraGTx Holdings (MeiraGTx Holdings) Business Description
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MGTX has been successfully added to your 